Synthesis of Aminobenzoic Acid-Based Nonpeptide Templates

Applications in Peptidomimetic Drug Discovery
  • Kimberly S. Para
  • Tomi K. Sawyer
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 23)


Aminobenzoic acid-based congeners are emerging as a useful class of nonpeptide templates for applications in peptidomimetic drug discovery. Exemplifying such compounds are recently described antagonists or inhibitors of several receptor and signal transduction protein targets, including, integrin gpIIbIIIa receptor antagonists (1), Ras farnesyl protein transferase inhibitors (2), Src SH2 domain antagonists (3), and growth hormone-releasing peptide (GHRP) receptor agonists (4). Representative examples of these compounds are shown in Fig. 1.
Fig. 1.

Chemical structures of integrin receptor antagonist, Ras famesyl protein transferase inhibitor, Src SH2 domain antagonist, and GHRP receptor agonist leads, which incorporate aminobenzoic acid-based nonpeptide templates.


Ethyl Acetate Citric Acid Hydroxylamine Hydrochloride Saturated Aqueous Solution Generic Template 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Qian, Y., Blaskovich, M. A., Saleem, M., Seong, CM., Wathen, S. P., Hamilton, A. D., et al. (1994) Design and structural requirements of potent peptidomimetic inhibitors of p21ras farnesyltransferase. J. Biol. Chem. 269, 12,410–12,413.Google Scholar
  2. 2.
    Jackson, S., DeGrado, W., Dwivedi, A., Parthasarathy, A., Higley, A., Krywko, J., et al. (1994) Template-constrained cyclic peptides: design of high-affinity ligands for GPIIb/IIIa. J. Amer. Chem. Soc. 116, 3220–3230.CrossRefGoogle Scholar
  3. 3.
    Lunney, E. A., Para, K. S., Plummer, M. S., Sawyer, T. K., Shahripour, A., Singh, J., et al. (1996) Intern. PCT Patent Application, Ser. No. WO9712903.Google Scholar
  4. 4.
    Peschke, B., Madsen, K., Hansen, B. S., and Johansen, N. L. (1997) Amino-methylthiophene-2-carboxylic acids as dipeptide mimetic in new growth hormone secretagogues. Bioorg. Med. Chem. Lett. 7, 1969–1972.CrossRefGoogle Scholar
  5. 5.
    Lunney, E. A., Para, K. S., Rubin, J. R., Humblet, C., Fergus, J., Marks, J., and Sawyer, T. K. (1997) Structure-based design of novel series of nonpeptide ligands that bind the pp60src SH2 domain. J. Amer. Chem. Soc. 119, 12471–12476.CrossRefGoogle Scholar
  6. 6.
    Para, K. S., Lunney, E. A., Plummer, M. S., Stankovic, C. J., Shahripour, A., Holland, D., et al. (1998) Structure-based de novo design and discovery of nonpeptide antagonists of the pp60src SH2 domain, in Proceedings of the Fifteenth American Peptide Symposium (Tarn, J. and Kaumaya, P., eds.), Escom Science Publishers, Leiden, the Netherlands, in press.Google Scholar
  7. 7.
    Sawyer, T. K. (1997) Peptidomimetric and nonpeptide drug discovery: Structure-based drug design, in Structure-Based Drug Design (Veerapandian, P., ed.), Marcel Dekker, New York, NY, pp. 559–634.Google Scholar
  8. 8.
    Sekiya, M., Yanaihara, N., and Masui, T. (1963) Reaction of amide homologs. Aminomethylation of salicyclic acid with N,N′-methylenebisacetamide. Chem. Pharm. Bull. 5, 551–553.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 1999

Authors and Affiliations

  • Kimberly S. Para
    • 1
  • Tomi K. Sawyer
    • 2
  1. 1.Parke-Davis Pharmaceutical ResearchAnn Arbor
  2. 2.Department of Organic ChemistryParke-Davis Pharmaceutical ResearchAnn Arbor

Personalised recommendations